EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Scaffold Protein Liprin β-1 (PPFIBP1) and the Intermediate Filament Synemin: Potential New Markers of Lymphatic Endothelial Cells

Jürgen Becker, Jörg Wilting iD

Cells · 10.06.2026 · 15 (12) · 1064

DOI: 10.3390/cells15121064 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 10.06.2026. Verfasst von Jürgen Becker und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy and Cell Biology, University Medical Center Göttingen, Kreuzbergring 36, 37075 Göttingen, Germany. Hauptthemen laut MEDLINE: Endothelial Cells, Adaptor Proteins, Signal Transducing. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There are a few molecules that are regularly used as markers for lymphatic endothelial cells (LECs) such as the adhesion molecule CD31/PEACAM1, the transcription factor PROX1, the Vascular Endothelial Growth Factor Receptor-3 (VEGFR3/FLT4), the glycoprotein podoplanin, and the hyaluronan receptor LYVE1. However, none of the molecules are exclusively expressed in LECs, and there is molecular and functional heterogeneity of LECs in initial lymphatics, lymphatic collectors and lymph nodes. Therefore, a combination of markers must be applied to identify lymphatics. This is particularly true for the characterization of conditions such as lymphatic malformations or cancers, in which the molecular profile of vessels may be variable or abnormal. Here we present two molecules that can help distinguish between endothelial cells of blood and lymphatic vessels: the scaffold protein liprin β-1 (PPFIBP1) and the intermediate filament synemin. We collected own data on the RNA and protein expression of the two molecules in humans, and studied publicly available databases. PPFIBP1 appears to be a suitable marker of LECs in initial lymphatics, collectors and lymph nodes, while synemin appears to be more restricted to initial lymphatics. We hope this will stimulate monoclonal antibody development and help expand the range of LEC markers in health and disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endothelial CellsAdaptor Proteins, Signal TransducingHumansBiomarkersAnimals

Stichwörter der Autor:innen

PPFIBP1SPHK1desminliprin β-1lymphatic vesselsynemin

Substanzen

BiomarkersAdaptor Proteins, Signal Transducing

Autor:innen und Institutionen

  • Department of Anatomy and Cell Biology, University Medical Center Göttingen, Kreuzbergring 36, 37075 Göttingen, Germany.

ORCID-Profile: Jörg Wilting

Zitieren

APA

Becker, J., & Wilting, J. (2026). The Scaffold Protein Liprin β-1 (PPFIBP1) and the Intermediate Filament Synemin: Potential New Markers of Lymphatic Endothelial Cells. Cells, 15(12), 1064. https://doi.org/10.3390/cells15121064

Vancouver

Becker J, Wilting J. The Scaffold Protein Liprin β-1 (PPFIBP1) and the Intermediate Filament Synemin: Potential New Markers of Lymphatic Endothelial Cells. Cells. 2026;15(12):1064. doi:10.3390/cells15121064

BibTeX
@article{Becker2026,
  author = {Becker, Jürgen and Wilting, Jörg},
  title = {The Scaffold Protein Liprin β-1 (PPFIBP1) and the Intermediate Filament Synemin: Potential New Markers of Lymphatic Endothelial Cells},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {12},
  pages = {1064},
  doi = {10.3390/cells15121064}
}
Kostenlos starten →